AnalystBook Research · Company Intelligence

Akso Health Group

AHGNasdaq

Built from Akso Health Group's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

The read at a glance

Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.

  • Distress risk · Altman Z-Score 10.89 safe zoneOK

Where the revenue comes from

Fiscal 2025, as Akso Health Group reports it. History and quarterly detail are in the app.

  • Revenue$14.8M
  • Revenue From Marketing Promotion Service$14.4M
  • Revenue From Sale Of Medical Devices$415K

Latest filings

  • 6-K · Company announcement (foreign filer)2026-05-13
  • 6-K · Company announcement (foreign filer)2026-03-23
  • 6-K · Company announcement (foreign filer)2026-02-10
  • 20-F · Annual report (foreign filer)2025-08-14
  • 6-K · Company announcement (foreign filer)2025-05-01
In the full recordFree for 14 days
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Akso Health Group, every answer cited to the official filings🔒
  • The Intelligence Brief — added when Akso Health Group's brief passes our SEC-figure check🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.